New Zealand Pharmaceuticals announces the merger with ICE Group

Palmerston North, New Zealand

17 August 2020

New Zealand Pharmaceuticals (NZP) is proud to announce that as of today, 17th August 2020, NZP will be joining the ICE Group.

Founded more than sixty years ago, ICE Group is a well-established global player in bile-related products, with a network of specialist facilities around the world. ICE’s main product is UDCA, a key ingredient in drugs treating liver conditions. ICE is based in Reggio Emilia, Italy, and has a global footprint with subsidiaries in Europe, APAC and the Americas.

For further details, please refer to the press release at this link.